Compare FKWL & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | FKWL | IXHL |
|---|---|---|
| Founded | 1981 | 2001 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | |
| Sector | Utilities | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.3M | 42.1M |
| IPO Year | 1997 | 2024 |
| Metric | FKWL | IXHL |
|---|---|---|
| Price | $2.94 | $3.37 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | 39.7K | ★ 244.3K |
| Earning Date | 05-15-2026 | 05-15-2026 |
| Dividend Yield | ★ 1.10% | N/A |
| EPS Growth | ★ 94.12 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $46,086,901.00 | $12,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $7.14 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 49.65 | N/A |
| 52 Week Low | $2.88 | $0.16 |
| 52 Week High | $5.48 | $6.39 |
| Indicator | FKWL | IXHL |
|---|---|---|
| Relative Strength Index (RSI) | 34.43 | 41.51 |
| Support Level | N/A | $0.33 |
| Resistance Level | $4.42 | $3.68 |
| Average True Range (ATR) | 0.14 | 0.30 |
| MACD | -0.02 | -0.11 |
| Stochastic Oscillator | 23.62 | 20.62 |
Franklin Wireless Corp is a provider of wireless solutions, including mobile hotspots, routers, and modems, as well as hardware and software products that support machine-to-machine (M2M) applications and the Internet of Things (IoT). Its M2M and IoT solutions include embedded modules, modems, and gateways built to deliver reliable always-on connectivity supporting a spectrum of applications. These products are designed to solve wireless connectivity challenges in a range of vertical markets, including video surveillance, digital signage, home security, oil and gas exploration, kiosks, fleet management, smart grid, vehicle diagnostics, and telematics.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.